Brian G Atwood - Net Worth and Insider Trading

Brian G Atwood Net Worth

The estimated net worth of Brian G Atwood is at least $42 Million dollars as of 2024-12-26. Brian G Atwood is the Director of Five Prime Therapeutics Inc and owns about 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $42 Million. Brian G Atwood is also the Director, 10% Owner of OpGen Inc and owns about 26 shares of OpGen Inc (OPGN) stock worth over $16. Details can be seen in Brian G Atwood's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian G Atwood has not made any transactions after 2015-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Brian G Atwood

Brian G Atwood Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian G Atwood owns 17 companies in total, including Atreca Inc (BCEL) , Clovis Oncology Inc (CLVSQ) , and PhaseRx Inc (PZRXQ) among others .

Click here to see the complete history of Brian G Atwood’s form 4 insider trades.

Insider Ownership Summary of Brian G Atwood

Ticker	Comapny	Transaction Date	Type of Owner
BCEL	Atreca Inc	2019-06-19	director
CLVSQ	Clovis Oncology Inc	2016-06-09	director
PZRXQ	PhaseRx Inc	2017-05-25	director & 10 percent owner
		2015-05-08	director
		2013-10-29	director & 10 percent owner
		2016-06-08	10 percent owner
		2015-06-24	10 percent owner
		2016-01-04	director
		2015-06-12	director
		2014-09-09	10 percent owner
		2014-11-18	10 percent owner
		2007-05-14	10 percent owner
		2006-05-09	10 percent owner
		2006-03-13	other: Former 10% Holder
		2021-01-07	director
		2021-10-05	director
		2014-11-18	10 percent owner

Brian G Atwood Latest Holdings Summary

Brian G Atwood currently owns a total of 2 stocks. Among these stocks, Brian G Atwood owns 1,092,152 shares of Five Prime Therapeutics Inc (FPRX) as of September 23, 2013, with a value of $42 Million and a weighting of 100%. Brian G Atwood also owns 26 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $16 and a weighting of 0%.

Latest Holdings of Brian G Atwood

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FPRX	Five Prime Therapeutics Inc	2013-09-23	1,092,152	38.00	41,501,776
OPGN	OpGen Inc	2015-05-08	26	0.62	16

Holding Weightings of Brian G Atwood

Brian G Atwood Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the acquisition of 76,923 shares on September 23, 2013, which cost Brian G Atwood around $999,999.

According to the SEC Form 4 filings, Brian G Atwood has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 4 shares on May 8, 2015, which cost Brian G Atwood around $2 Million.

Insider Trading History of Brian G Atwood

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian G Atwood Trading Performance

GuruFocus tracks the stock performance after each of Brian G Atwood's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian G Atwood is -7.87%. GuruFocus also compares Brian G Atwood's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian G Atwood within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian G Atwood's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian G Atwood

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	3.65
Relative Return to S&P 500(%)	3.21

Brian G Atwood Ownership Network

Ownership Network List of Brian G Atwood

No Data

Ownership Network Relation of Brian G Atwood

Brian G Atwood Owned Company Details

What does Atreca Inc do?

Who are the key executives at Atreca Inc?

Brian G Atwood is the director of Atreca Inc. Other key executives at Atreca Inc include director & Chief Strategy Officer Tito Serafini , other: Former 10% Owner Felix Baker , and other: Former 10% Owner Baker Bros. Advisors Lp .

Atreca Inc (BCEL) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 0 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Atreca Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Brian G Atwood is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does PhaseRx Inc do?

Who are the key executives at PhaseRx Inc?

Brian G Atwood is the director & 10 percent owner of PhaseRx Inc. Other key executives at PhaseRx Inc include Chief Medical Officer Gordon Brandt , director & 10 percent owner Steven Gillis , and 10 percent owner Robert Nelsen .

PhaseRx Inc (PZRXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseRx Inc Insider Transactions

No Available Data

What does OpGen Inc do?

Who are the key executives at OpGen Inc?

Brian G Atwood is the director of OpGen Inc. Other key executives at OpGen Inc include Chief Operating Officer Johannes Bacher , Chief Finanical Officer Albert Weber , and director & Chief Executive Officer Oliver Schacht .

OpGen Inc (OPGN) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in OpGen Inc (OPGN). Other recent insider transactions involving OpGen Inc (OPGN) include a net purchase of 5,245,603 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of OpGen Inc (OPGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,400,000 shares of OpGen Inc (OPGN) were sold and 7,645,603 shares were bought by its insiders, resulting in a net purchase of 5,245,603 shares.

OpGen Inc (OPGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

OpGen Inc Insider Transactions

No Available Data

What does Veracyte Inc do?

Who are the key executives at Veracyte Inc?

Brian G Atwood is the director & 10 percent owner of Veracyte Inc. Other key executives at Veracyte Inc include Chief Executive Officer Marc Stapley , Chief Scientific & Med Officer Phillip G. Febbo , and SVP & General Counsel Annie Mcguire .

Veracyte Inc (VCYT) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Veracyte Inc (VCYT). Other recent insider transactions involving Veracyte Inc (VCYT) include a net sale of 131,749 shares made by Evan/ Fa Jones , a net sale of 28,601 shares made by Karin Eastham , and a net sale of 7,806 shares made by John Leite .

In summary, during the past 3 months, insiders sold 87,267 shares of Veracyte Inc (VCYT) in total and bought 0 shares, with a net sale of 87,267 shares. During the past 18 months, 275,051 shares of Veracyte Inc (VCYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 275,051 shares.

Veracyte Inc (VCYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Veracyte Inc Insider Transactions

No Available Data

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Brian G Atwood is the 10 percent owner of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include General Counsel Mark S. Levine , Chief Regulatory Officer Kerry Wentworth , and Chief Strategy Officer Christina Willwerth .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Flexion Therapeutics Inc Insider Transactions

No Available Data

What does Glaukos Corp do?

Who are the key executives at Glaukos Corp?

Brian G Atwood is the 10 percent owner of Glaukos Corp. Other key executives at Glaukos Corp include CFO & SVP Corporate Development Joseph E Gilliam , SVP & Chief Financial Officer Alex R. Thurman , and director & 10 percent owner & Chief Executive Officer Thomas William Burns .

Glaukos Corp (GKOS) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Glaukos Corp (GKOS). Other recent insider transactions involving Glaukos Corp (GKOS) include a net sale of 314,757 shares made by Joseph E Gilliam , a net sale of 471,810 shares made by Thomas William Burns , and a net sale of 6,762 shares made by Alex R. Thurman .

In summary, during the past 3 months, insiders sold 17,603 shares of Glaukos Corp (GKOS) in total and bought 0 shares, with a net sale of 17,603 shares. During the past 18 months, 909,236 shares of Glaukos Corp (GKOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 909,236 shares.

Glaukos Corp (GKOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glaukos Corp Insider Transactions

No Available Data

What does Immune Design Corp do?

Who are the key executives at Immune Design Corp?

Brian G Atwood is the director of Immune Design Corp. Other key executives at Immune Design Corp include 10 percent owner & other: General Partner Column Group Gp, Lp , 10 percent owner Column Group L P , and 10 percent owner & other: General Partner Ponoi Management, Llc .

Immune Design Corp (IMDZ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp (IMDZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp (IMDZ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp (IMDZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immune Design Corp Insider Transactions

No Available Data

What does Five Prime Therapeutics Inc do?

Who are the key executives at Five Prime Therapeutics Inc?

Brian G Atwood is the director of Five Prime Therapeutics Inc. Other key executives at Five Prime Therapeutics Inc include 10 percent owner Biotechnology Value Fund L P , 10 percent owner Bvf Inc/il , and 10 percent owner Bvf Gp Holdings Llc .

Five Prime Therapeutics Inc (FPRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc (FPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc (FPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Five Prime Therapeutics Inc (FPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Five Prime Therapeutics Inc Insider Transactions

No Available Data

What does Inogen Inc do?

Who are the key executives at Inogen Inc?

Brian G Atwood is the 10 percent owner of Inogen Inc. Other key executives at Inogen Inc include EVP & Gen. Counsel & Secretary Jason Somer , EVP & Chief Medical Officer Stanislav Glezer , and EVP & CFO and Treasurer Kristin A. Caltrider .

Inogen Inc (INGN) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Inogen Inc (INGN). Other recent insider transactions involving Inogen Inc (INGN) include a net sale of 10,000 shares made by Jason Somer ,

In summary, during the past 3 months, insiders sold 0 shares of Inogen Inc (INGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,000 shares of Inogen Inc (INGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,000 shares.

Inogen Inc (INGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inogen Inc Insider Transactions

No Available Data

What does Second Sight Medical Products Inc do?

Who are the key executives at Second Sight Medical Products Inc?

Brian G Atwood is the 10 percent owner of Second Sight Medical Products Inc. Other key executives at Second Sight Medical Products Inc include Chief Medical Officer Lisa Ellen Porter , Chief Business Officer Donald Dwyer , and COO Truc Le .

Second Sight Medical Products Inc (EYES) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Second Sight Medical Products Inc (EYES) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Second Sight Medical Products Inc (EYES) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Second Sight Medical Products Inc (EYES)'s detailed insider trading history can be found in Insider Trading Tracker table.

Second Sight Medical Products Inc Insider Transactions

No Available Data

What does Insulet Corp do?

Who are the key executives at Insulet Corp?

Brian G Atwood is the 10 percent owner of Insulet Corp. Other key executives at Insulet Corp include SVP & R&D & New Prod Dev. & Comm Eric Benjamin , VP & CAO and Controller Lauren Budden , and SVP & Chief Technology Officer Mark N Field .

Insulet Corp (PODD) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Insulet Corp (PODD). Other recent insider transactions involving Insulet Corp (PODD) include a net sale of 6,401 shares made by Mark N Field , a net sale of 15,300 shares made by Timothy J Scannell , and a net sale of 940 shares made by Luciana Borio .

In summary, during the past 3 months, insiders sold 5,785 shares of Insulet Corp (PODD) in total and bought 0 shares, with a net sale of 5,785 shares. During the past 18 months, 86,873 shares of Insulet Corp (PODD) were sold and 5,651 shares were bought by its insiders, resulting in a net sale of 81,222 shares.

Insulet Corp (PODD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Insulet Corp Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Brian G Atwood is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Alexza Pharmaceuticals Inc do?

Who are the key executives at Alexza Pharmaceuticals Inc?

Brian G Atwood is the other: Former 10% Holder of Alexza Pharmaceuticals Inc. Other key executives at Alexza Pharmaceuticals Inc include director & President & CEO Thomas Braxton King , Former SVP & CFO & Secretary Mark K Oki , and EVP & Operations & COO Robert A Lippe .

Alexza Pharmaceuticals Inc (ALXA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexza Pharmaceuticals Inc (ALXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexza Pharmaceuticals Inc (ALXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexza Pharmaceuticals Inc (ALXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alexza Pharmaceuticals Inc Insider Transactions

No Available Data

What does eFFECTOR Therapeutics Inc do?

Who are the key executives at eFFECTOR Therapeutics Inc?

Brian G Atwood is the director of eFFECTOR Therapeutics Inc. Other key executives at eFFECTOR Therapeutics Inc include 10 percent owner Sr One Capital Fund I Aggregator Lp , director & 10 percent owner & Chief Executive Officer Christopher B Ehrlich , and Chief Business Officer Mayank Gandhi .

eFFECTOR Therapeutics Inc (EFTR) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in eFFECTOR Therapeutics Inc (EFTR). Other recent insider transactions involving eFFECTOR Therapeutics Inc (EFTR) include a net sale of 609,163 shares made by Sr One Capital Fund I Aggregator Lp ,

In summary, during the past 3 months, insiders sold 0 shares of eFFECTOR Therapeutics Inc (EFTR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 24,367 shares of eFFECTOR Therapeutics Inc (EFTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 24,367 shares.

eFFECTOR Therapeutics Inc (EFTR)'s detailed insider trading history can be found in Insider Trading Tracker table.

eFFECTOR Therapeutics Inc Insider Transactions

No Available Data

What does Phoenix Biotech Acquisition Corp do?

Who are the key executives at Phoenix Biotech Acquisition Corp?

Brian G Atwood is the director of Phoenix Biotech Acquisition Corp. Other key executives at Phoenix Biotech Acquisition Corp include director & 10 percent owner & CEO and and Secretary Christopher B Ehrlich , President Douglas Fisher , and Chief Financial Officer Daniel E. Geffken .

Phoenix Biotech Acquisition Corp (PBAX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Phoenix Biotech Acquisition Corp (PBAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Phoenix Biotech Acquisition Corp (PBAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Phoenix Biotech Acquisition Corp (PBAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Phoenix Biotech Acquisition Corp Insider Transactions

No Available Data

What does Vivani Medical Inc do?

Who are the key executives at Vivani Medical Inc?

Brian G Atwood is the 10 percent owner of Vivani Medical Inc. Other key executives at Vivani Medical Inc include director & 10 percent owner Gregg Williams , Chief Business Officer Donald Dwyer , and CFO Brigid Makes .

Vivani Medical Inc (VANI) Insider Trades Summary

Over the past 18 months, Brian G Atwood made no insider transaction in Vivani Medical Inc (VANI). Other recent insider transactions involving Vivani Medical Inc (VANI) include a net purchase of 4,695,861 shares made by Gregg Williams , a net purchase of 35,000 shares made by Donald Dwyer , and a net purchase of 15,000 shares made by Brigid Makes .

In summary, during the past 3 months, insiders sold 0 shares of Vivani Medical Inc (VANI) in total and bought 3,970,753 shares, with a net purchase of 3,970,753 shares. During the past 18 months, 0 shares of Vivani Medical Inc (VANI) were sold and 4,745,861 shares were bought by its insiders, resulting in a net purchase of 4,745,861 shares.

Vivani Medical Inc (VANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vivani Medical Inc Insider Transactions

No Available Data

Brian G Atwood Mailing Address

Above is the net worth, insider trading, and ownership report for Brian G Atwood. You might contact Brian G Atwood via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.

Discussions on Brian G Atwood

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.